159 related articles for article (PubMed ID: 27845153)
1. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.
DiPippo AJ; Tverdek FP; Tarrand JJ; Munita JM; Tran TT; Arias CA; Shelburne SA; Aitken SL
J Infect; 2017 Mar; 74(3):243-247. PubMed ID: 27845153
[TBL] [Abstract][Full Text] [Related]
2. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Britt NS; Potter EM; Patel N; Steed ME
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
[TBL] [Abstract][Full Text] [Related]
3. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
[TBL] [Abstract][Full Text] [Related]
5. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy.
Lewis JS; Owens A; Cadena J; Sabol K; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2005 Apr; 49(4):1664-5. PubMed ID: 15793168
[No Abstract] [Full Text] [Related]
6. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Britt NS; Potter EM; Patel N; Steed ME
Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
[TBL] [Abstract][Full Text] [Related]
7. Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
Patel K; Kabir R; Ahmad S; Allen SL
J Oncol Pharm Pract; 2016 Apr; 22(2):212-8. PubMed ID: 25326010
[TBL] [Abstract][Full Text] [Related]
8. Failure of high-dose daptomycin for bacteremia caused by daptomycin-susceptible Enterococcus faecium harboring LiaSR substitutions.
Munita JM; Mishra NN; Alvarez D; Tran TT; Diaz L; Panesso D; Reyes J; Murray BE; Adachi JA; Bayer AS; Arias CA
Clin Infect Dis; 2014 Nov; 59(9):1277-80. PubMed ID: 25107294
[TBL] [Abstract][Full Text] [Related]
9. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
[TBL] [Abstract][Full Text] [Related]
10. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
11. Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
Int J Antimicrob Agents; 2019 Nov; 54(5):572-578. PubMed ID: 31476435
[TBL] [Abstract][Full Text] [Related]
12. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
14. Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance.
Chuang YC; Lin HY; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Crit Care Med; 2018 Oct; 46(10):1634-1642. PubMed ID: 29957707
[TBL] [Abstract][Full Text] [Related]
15. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
[TBL] [Abstract][Full Text] [Related]
16. Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.
Kinnear CL; Patel TS; Young CL; Marshall V; Newton DW; Read AF; Woods RJ
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718245
[TBL] [Abstract][Full Text] [Related]
17. Clinical Characteristics and Low Susceptibility to Daptomycin in Enterococcus faecium Bacteremia.
Namikawa H; Yamada K; Shibata W; Fujimoto H; Takizawa E; Niki M; Nakaie K; Nakamura Y; Oinuma KI; Niki M; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
Tohoku J Exp Med; 2017 Nov; 243(3):211-218. PubMed ID: 29187672
[TBL] [Abstract][Full Text] [Related]
18. Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis.
Egli A; Schmid H; Kuenzli E; Widmer AF; Battegay M; Plagge H; Frei R; Achermann R; Weisser M
Clin Microbiol Infect; 2017 Feb; 23(2):118.e1-118.e7. PubMed ID: 27746397
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections.
King ST; Usery JB; Holloway K; Koeth L; Cleveland KO; Gelfand MS
J Antimicrob Chemother; 2011 Nov; 66(11):2673-5. PubMed ID: 21846674
[No Abstract] [Full Text] [Related]
[Next] [New Search]
